Discuss your study

Dermis connects you with the right patients.

We find the patients your study needs, and make it easy for them to see it through.

Discuss your studySee how it works
Patient
Maya sees a study ad
Patient
She takes a quick pre-screen
Patient
She logs by voice
“Itchy again, about a 7.”
Your team
You see everything, live

The problem

Most trials reach their patient goals. They just take longer and cost more than anyone planned.

~$40,000Tufts CSDD · 2024A 2024 analysis from the Tufts Center for the Study of Drug Development puts the direct cost of a day of delay at roughly $40,000 for Phase II and III trials. Direct costs only.Read the source /day

in direct costs when a Phase II or III trial is delayed.

Bridging the gap between you and your patients.

We find the patients who match your study, and help them stick with it.

What we do

Two standalone products. One finds your patients, one keeps them.

Recruitment

Finds the right patients

Outreach, pre-screening and referrals to your sites.

Steps 01 – 02
Retention

Keeps them in your trial

A logging app patients actually use, and live data for your team.

Steps 03 – 04
Recruitment01 — Reach

Outreach that sounds like it understands them.

Messages, creative and channels shaped around how people actually talk about living with their condition. Not a generic recruitment ad.

What the patient sees
Recruitment02 — Pre-screen

A few questions, right where they are.

Interested people answer a short pre-screen in the same moment. No forms to download, no phone tag. Qualified patients are referred to your sites.

What the patient sees
Retention03 — Between visits

Logging that takes seconds.

When it’s this easy, patients keep doing it. Everything is sorted for them, and an opt-in nudge, like a quick log before opening a favorite app, helps it become a habit.

What the patient sees
Retention04 — Your view

Clean, current data for your team.

Every entry arrives sorted and timestamped, so your data is always current. Itch, sleep, stress, diet and cycle sit on one timeline, and gaps show up early.

What your team sees
9:41
SSponsored

Planning your week around flare-ups?

See if you qualify
9:41
2 of 4
How is your eczema right now?
Mild
Moderate
Severe
Continue
9:41
Today
Listening

Itchy again, about a 7. Woke up twice last night.

Itch7
SleepWoke 2×
DoseTaken
Participant 014Atopic dermatitis
ItchSleepStressCycleDietSep 26Oct 6Oct 16Oct 26Nov 6
2 of 5 flares followed a short night and a stressful day.
On their phone

Handled with care

Every patient is a person first.

  • Ethics reviewPatient-facing materials go through your study’s ethics review before they go live.
  • Voluntary and clearPlain-language materials, no pressure, and every feature is opt-in.
  • Secure by designEncryption and access controls, hosted on Google Cloud under a signed BAA.

Why we’re here

Therapies shouldn’t have to wait.

Every extra day a trial runs is another day someone is still waiting for a treatment.

We start with the two places we can help most, finding patients and keeping them, to get therapies to the people who need them sooner.

Good to know

Simple answers to common questions.

No. We work alongside them.

Primarily Phase II and III and beyond, and we’re happy to talk about earlier stages.

No. You can start with recruitment.

Patients choose what they share. Their study team sees data from their own participants. Dermis stores it securely under a signed BAA.

Recruitment campaigns can typically start within days of agreement, depending on IRB approval.

Tell us about your study.

Thirty minutes. We’ll listen first.

Book a 30-minute call

Pick a time that works for you.

Discuss your study